The Novartis Pharmaceuticals Division is a world leader in the discovery, development, manufacture, and marketing of prescription medicine. Our goal is to provide a broad portfolio of innovative, effective and safe products and services to patients through healthcare professionals around the world. In 2004, the Pharmaceutical's business posted sales of USD 18.5 billion. Research & Development spending increased substantially and reached 18.8% of sales. Our current product portfolio includes more than 40 key marketed products, many of which are leaders in their respective therapeutical areas. The Development portfolio involves more than 75 projects - including potential new products as well as potential new indications or formulations for existing products - in various stages of clinical development.Product & ServicesThe Pharmaceutical Division consists of the following therapeutic areas: 1. General Medicines: A. Cardiovascular & Metabolism B. Neuroscience C. Respiratory & Dermatology D. ABGHI (Arthritis, bone, gastrointestinal, hormone replacement therapies, urinary incontinence) E. Infectious diseases 2. Specialty Medicines: A. Oncology & Hematology B. Transplantation & Immunology C. Ophthalmics
The Novartis Pharmaceuticals Division is a world leader in the discovery, development, manufacture, and marketing of prescription medicine. Our goal is to provide a broad portfolio of innovative, effective and safe products and services to patients through healthcare professionals around the world. In 2004, the Pharmaceutical's business posted sales of USD 18.5 billion. Research & Development spending increased substantially and reached 18.8% of sales. Our current product portfolio includes more than 40 key marketed products, many of which are leaders in their respective therapeutical areas. The Development portfolio involves more than 75 projects - including potential new products as well as potential new indications or formulations for existing products - in various stages of clinical development.Product & ServicesThe Pharmaceutical Division consists of the following therapeutic areas: 1. General Medicines: A. Cardiovascular & Metabolism B. Neuroscience C. Respiratory & Dermatology D. ABGHI (Arthritis, bone, gastrointestinal, hormone replacement therapies, urinary incontinence) E. Infectious diseases 2. Specialty Medicines: A. Oncology & Hematology B. Transplantation & Immunology C. Ophthalmics
The Novartis Pharmaceuticals Division is a world leader in the discovery, development, manufacture, and marketing of prescription medicine. Our goal is to provide a broad portfolio of innovative, effective and safe products and services to patients through healthcare professionals around the world. In 2004, the Pharmaceutical's business posted sales of USD 18.5 billion. Research & Development spending increased substantially and reached 18.8% of sales. Our current product portfolio includes more than 40 key marketed products, many of which are leaders in their respective therapeutical areas. The Development portfolio involves more than 75 projects - including potential new products as well as potential new indications or formulations for existing products - in various stages of clinical development.Product & ServicesThe Pharmaceutical Division consists of the following therapeutic areas: 1. General Medicines: A. Cardiovascular & Metabolism B. Neuroscience C. Respiratory & Dermatology D. ABGHI (Arthritis, bone, gastrointestinal, hormone replacement therapies, urinary incontinence) E. Infectious diseases 2. Specialty Medicines: A. Oncology & Hematology B. Transplantation & Immunology C. Ophthalmics